BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 36200553)

  • 1. Leprosy Caused by Mycobacterium lepromatosis.
    Romero-Navarrete M; Arenas R; Han XY; Vega-Memije ME; Castillo-Solana AD
    Am J Clin Pathol; 2022 Dec; 158(6):678-686. PubMed ID: 36200553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico.
    Han XY; Sizer KC; Velarde-Félix JS; Frias-Castro LO; Vargas-Ocampo F
    Int J Dermatol; 2012 Aug; 51(8):952-9. PubMed ID: 22788812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis.
    Silva FJ; Santos-Garcia D; Zheng X; Zhang L; Han XY
    Microbiol Spectr; 2022 Jun; 10(3):e0169221. PubMed ID: 35467405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review of Hansen Disease Attributed to Mycobacterium lepromatosis.
    Collin SM; Lima A; Heringer S; Sanders V; Pessotti HA; Deps P
    Emerg Infect Dis; 2023 Jul; 29(7):1376-1385. PubMed ID: 37347507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic characterization of Mycobacterium lepromatosis from ENL patients from India.
    Singh I; Pathak VK; Lavania M; Ahuja M; Sharma R; Narang T; Jain S; Turankar RP; Dogra S; Sengupta U
    Infect Genet Evol; 2023 Dec; 116():105537. PubMed ID: 38056703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective amelioration of the Lucio phenomenon with adjuvant tofacitinib therapy in a patient with dual infection of
    Patel NH; Padhiyar JK; Patel KA; Patel JR; Lakum MP; Singh I
    Access Microbiol; 2023; 5(10):. PubMed ID: 37970083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse vaccinology and subtractive genomics approaches for identifying common therapeutics against
    Jaiswal AK; Tiwari S; Jamal SB; Oliveira LC; Sales-Campos H; Andrade-Silva LE; Oliveira CJF; Ghosh P; Barh D; Azevedo V; Soares SC; Rodrigues VR; da Silva MV
    J Venom Anim Toxins Incl Trop Dis; 2021 Apr; 27():e20200027. PubMed ID: 33889182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteological, biomolecular and geochemical examination of an early anglo-saxon case of lepromatous leprosy.
    Inskip SA; Taylor GM; Zakrzewski SR; Mays SA; Pike AW; Llewellyn G; Williams CM; Lee OY; Wu HH; Minnikin DE; Besra GS; Stewart GR
    PLoS One; 2015; 10(5):e0124282. PubMed ID: 25970602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. This Month in JAADCase Reports: May 2024 Mycobacterium lepromatosis in Wisconsin.
    Sloan B
    J Am Acad Dermatol; 2024 May; 90(5):931. PubMed ID: 38387854
    [No Abstract]   [Full Text] [Related]  

  • 10. Target product profiles: leprosy diagnostics.
    Kukkaro P; Vedithi SC; Blok DJ; van Brakel WH; Geluk A; Srikantam A; Scollard D; Adams LB; Duck M; Anand S; Tucker A; Cruz I; Pemmaraju V; Dagne DA; Asiedu K; Hanna C
    Bull World Health Organ; 2024 Apr; 102(4):288-295. PubMed ID: 38562197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lepromatous Leprosy Manifesting As Chronic Macrocheilia: Report of a Rare Case.
    Panigrahi R; Priyadarshini SR; Sahoo PK; Alam T; Saeed S; Hasan S
    Cureus; 2023 Oct; 15(10):e47859. PubMed ID: 38021977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy in children in Cuba: Epidemiological and clinical description of 50 cases from 2012-2019.
    Rumbaut Castillo R; Hurtado Gascón LC; Ruiz-Fuentes JL; Pastrana Fundora FM; Ramírez Albajés CR; Henao-Martínez AF; Franco-Paredes C; Escobedo ÁA
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009910. PubMed ID: 34710091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic approach for repurposing immunomodulatory drugs for lepromatous leprosy.
    Espitia GJ; Arenas NE; Gutiérrez-Castañeda LD; Guerrero MI
    Int J Mycobacteriol; 2023; 12(4):388-393. PubMed ID: 38149532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leprosy Classification, Clinical Features, Epidemiology, and Host Immunological Responses: Failure of Eradication in 2023.
    Alrehaili J
    Cureus; 2023 Sep; 15(9):e44767. PubMed ID: 37809252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-infection of
    Ruthramoorthy P; Jose JA; Revendran J; Elango R
    Int J Mycobacteriol; 2023; 12(4):513-515. PubMed ID: 38149553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hansen's Disease: A Practical Update on a Neglected Globally Significant Infection.
    Benlamkadam S; Errahmany A; Raymond K; Chraa M; Kissani N
    Cureus; 2024 Apr; 16(4):e57374. PubMed ID: 38694670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprosy mimicking autoimmune diseases: a case series.
    Aride DB; Dalmaso BF; Moulin ACS; Moulaz IR; Machado KLLL
    Clin Exp Rheumatol; 2024 Mar; 42(3):746-751. PubMed ID: 38372720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leprosy Reactions: Unraveling Immunological Mechanisms Underlying Tissue Damage in Leprosy Patients.
    Serrano-Coll H; Wan EL; Restrepo-Rivera L; Cardona-Castro N
    Pathog Dis; 2024 May; ():. PubMed ID: 38806255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coinfection with Leprosy and Tuberculosis: A Case Series in Malagasy Patients.
    Rakotoarisaona MF; Razafimaharo TI; Sendrasoa FA; Andrianarison M; Razanakoto NH; Ratovonjanahary VT; Raharolahy O; Ranaivo IM; Ramarozatovo LS; Rapelanoro Rabenja F
    Infect Drug Resist; 2024; 17():1507-1513. PubMed ID: 38645889
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.